Rank Bio Products India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 1.67 Cr
as on 12-07-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.84 M
as on 12-07-2024
- Revenue -15.87%
(FY 2020)
- Profit -30.04%
(FY 2020)
- Ebitda -5.95%
(FY 2020)
- Net Worth 11.01%
(FY 2020)
- Total Assets 5.26%
(FY 2020)
About Rank Bio Products India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.67 Cr.
The company currently has active open charges totaling ₹9.84 M.
Navin Sekar and Sekar Vijay serve as directors at the Company.
- CIN/LLPIN
U24119TZ2014PTC020537
- Company No.
020537
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Rank Bio Products India Private Limited offer?
Rank Bio Products India Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic,Herbal Products & Medicine, Herbal Capsules.
Who are the key members and board of directors at Rank Bio Products India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sekar Vijay | Managing Director | 21-Apr-2022 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Navin Sekar | Director | 21-Apr-2022 | Current |
Financial Performance of Rank Bio Products India.
Rank Bio Products India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 15.87% decrease. The company also saw a substantial fall in profitability, with a 30.04% decrease in profit. The company's net worth Soared by an impressive increase of 11.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Rank Bio Products India?
In 2018, Rank Bio Products India had a promoter holding of 12.63% and a public holding of 87.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Pars Engineering India Private LimitedActive 11 years 1 month
Navin Sekar and Sekar Vijay are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 06 Oct 2018 | ₹4.92 M | Open |
Others Creation Date: 04 Oct 2018 | ₹4.92 M | Open |
How Many Employees Work at Rank Bio Products India?
Unlock and access historical data on people associated with Rank Bio Products India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rank Bio Products India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rank Bio Products India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.